CVS 2011 Annual Report Download - page 12

Download and view the complete annual report

Please find page 12 of the 2011 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 84

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84

CVS CAREMARK 10 2011 ANNUAL REPORT
Prescription-Based
THE INDUSTRY WAY:
Relationship-Based
Powered by our proprietary Consumer Engagement Engine™, the Pharmacy Advisor program places
critical information into our pharmacists’ workflow, whether they are at a PBM call center, mail order
pharmacy, or in one of our 7,300 retail pharmacy stores. This enables a helpful consultation with patients
on opportunities to improve medication adherence, close identified gaps in care as recommended by
clinical guidelines, improve their health, and lower overall health care costs.
The problem of non-adherence to prescribed drug therapies is estimated to cost the U.S. health care
system more than $300 billion annually. Research has demonstrated that patients with certain chronic
diseases who adhere to their drug regimens remain healthier, miss fewer days of work, and have
significantly lower health care costs.
Capitalizing on our integration “sweet spots,” we are creating a comprehensive care program based
on the best clinical information. We have already achieved powerful results for patients with diabetes,
the first disease state addressed by Pharmacy Advisor. In April 2012, Pharmacy Advisor will begin
addressing hyperlipidemia, hypertension, coronary artery disease, and congestive heart failure. We plan
to roll out programs for asthma/COPD, depression, cancer, and osteoporosis by the end of the year, with
GI disorders, rheumatoid arthritis, multiple sclerosis, and chronic kidney disease to be added in 2013.
P H A R M A C Y A D V I S O R :
Face-to-face counseling between pharmacists and patients
can be two to three times as effective as other forms of com-
munication in driving adherence to prescription drug regimens.
That insight helped lead to the creation of Pharmacy Advisor®
,
our flagship PBM program for integrated pharmacy care.